M B Plotnikov Selected Research

taxifolin

9/2019	Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia.
3/2018	Experimental Analysis of the Efficacy of Dihydroquercetin on the Model of Chronic Nonbacterial Inflammation of the Prostatic Gland.
5/2017	Dihydroquercetin Improves Microvascularization and Microcirculation in the Brain Cortex of SHR Rats during the Development of Arterial Hypertension.
1/2017	Modes of Hypotensive Action of Dihydroquercetin in Arterial Hypertension.
2/2015	Dihydroquercetin effects on the morphology and antioxidant/prooxidant balance of the prostate in rats with sulpiride-induced benign hyperplasia.
11/2011	Antioxidant composition causes antiexsudorific effect in the model of chronic venous insufficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M B Plotnikov Research Topics

Disease

9	Brain Ischemia (Cerebral Ischemia) 12/2019 - 10/2001
5	Myocardial Ischemia (Ischemic Heart Diseases) 05/2022 - 01/2003
4	Myocardial Infarction 05/2022 - 01/2003
4	Hypertension (High Blood Pressure) 05/2017 - 03/2000
4	Ischemia 07/2016 - 10/2001
3	Experimental Diabetes Mellitus 09/2010 - 12/2007
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2019 - 02/2015
2	Inflammation (Inflammations) 03/2018 - 04/2003
2	Transient Ischemic Attack 07/2016 - 01/2009
2	Edema (Dropsy) 11/2011 - 05/2003
2	Hepatitis 01/2011 - 08/2010
2	Cardiac Arrhythmias (Arrythmia) 07/2007 - 06/2007
2	Crush Syndrome 05/2004 - 10/2001
2	Brain Diseases (Brain Disorder) 01/2004 - 01/2004
2	Headache (Headaches) 01/2004 - 01/2004
1	Ventricular Remodeling 05/2022
1	Aneurysm (Aneurysms) 05/2022
1	Male Infertility (Male Sterility) 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Hyperplasia 02/2015
1	Venous Insufficiency 11/2011
1	Ganglion Cysts (Ganglion) 09/2010
1	Diabetes Mellitus 09/2010
1	Hypertrophy 02/2009
1	Thrombosis (Thrombus) 03/2008
1	Coronary Occlusion 07/2007
1	Brain Edema (Cerebral Edema) 05/2007
1	Hemorrhage 09/2006
1	Stroke (Strokes) 09/2006
1	Wounds and Injuries (Trauma) 11/2005
1	Body Weight (Weight, Body) 07/2005
1	Vertigo (Positional Vertigo) 01/2004
1	Sclerosis 01/2004
1	Atherosclerosis 01/2004
1	Arteriosclerosis 01/2004
1	Macular Degeneration (Age-Related Maculopathy) 05/2003
1	Scotoma (Scintillating Scotoma) 05/2003
1	Hypovolemia 10/2001
1	Neoplasms (Cancer) 01/2001

Drug/Important Bio-Agent (IBA)

9	AntioxidantsIBA 09/2019 - 01/2004
7	ascovertinIBA 02/2009 - 10/2001
6	taxifolinIBA 09/2019 - 11/2011
5	4-hydroxyphenylethanolIBA 05/2022 - 06/2007
4	Oxygen (Dioxygen)IBA 06/2014 - 10/2001
4	Phenol (Carbolic Acid)FDA Link 06/2014 - 03/2008
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2007 - 01/2003
3	Ethylene Oxide (Oxirane)IBA 09/2006 - 01/2003
2	Sulpiride (neogama)IBA 09/2019 - 02/2015
2	Neuroprotective AgentsIBA 11/2018 - 01/2009
2	salicylhydroxamic acid (SHAM)IBA 07/2016 - 06/2014
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2011 - 08/2010
2	Fibrinogen (Factor I)FDA Link 11/2010 - 03/2000
2	4-methyl-2,6-diisobornylphenolIBA 09/2010 - 01/2009
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2008 - 06/2006
2	LipidsIBA 07/2008 - 06/2006
2	SolutionsIBA 05/2007 - 05/2003
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2003 - 01/2003
2	diquertinIBA 03/2003 - 01/2003
1	Methimazole (Thiamazole)FDA LinkGeneric 09/2019
1	ethylmethylhydroxypyridine succinateIBA 10/2018
1	polyglucosanIBA 10/2018
1	LignansIBA 01/2017
1	IsoflavonesIBA 01/2017
1	Phytoestrogens (Phytoestrogen)IBA 01/2017
1	Fluoxetine (Prozac)FDA LinkGeneric 07/2016
1	Thioctic Acid (Lipoic Acid)IBA 11/2011
1	thiophaneIBA 01/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2011
1	Pyruvic Acid (Pyruvate)IBA 01/2011
1	Streptozocin (Streptozotocin)FDA Link 09/2010
1	PhenolsIBA 01/2009
1	PhosphatidylserinesIBA 07/2008
1	SphingomyelinsIBA 07/2008
1	LysophospholipidsIBA 07/2008
1	Therapeutic UsesIBA 07/2007
1	Ecdysterone (20 Hydroxyecdysone)IBA 07/2005
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 03/2005
1	Pharmaceutical PreparationsIBA 01/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2001
1	SuspensionsIBA 01/2001

Therapy/Procedure

5	Therapeutics 09/2019 - 01/2003
2	Intravenous Administration 01/2010 - 05/2003
1	Lasers (Laser) 05/2017
1	Injections 02/2015
1	Intravenous Injections 05/2007